Despite compulsory licensing generic cancer drug too costly for the poor
Despite the ruling earlier this week that allowed Natco, an Indian pharmacy to copy Bayer’s Nexavar, a blockbuster cancer drug that will bring down the price by 97%, the generic cancer drug is still too costly for most people. The generic version of the drug, German drug-maker Bayer's
April 23 2013, 4:46 pm
Read More

